You have 9 free searches left this month | for more free features.

CD122-Preferential

Showing 1 - 25 of 1,079

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

Not yet recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Biospecimen Collection
  • +9 more
  • Los Angeles, California
    Yonemoto,Lisa
Jan 13, 2023

Metastatic Melanoma Trial in Duarte, Portland, Philadelphia (Bempegaldesleukin (NKTR-214), Nivolumab, 8?Zr-Df-IAB22M2C)

Withdrawn
  • Metastatic Melanoma
  • Bempegaldesleukin (NKTR-214)
  • +2 more
  • Duarte, California
  • +2 more
Jun 28, 2021

Follicular Lymphoma Trial in Worldwide (HCD122)

Completed
  • Follicular Lymphoma
  • Boston, Massachusetts
  • +11 more
Dec 6, 2020

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • bempegaldesleukin
  • +3 more
  • Anchorage, Alaska
  • +108 more
Mar 31, 2022

Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)

Completed
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • Tucson, Arizona
  • +1 more
Jan 9, 2023

Paroxysmal Atrial Fibrillation Trial in Madrid (Vernakalant, Flecainide)

Recruiting
  • Paroxysmal Atrial Fibrillation
  • Madrid, Madrid/Madrid, Spain
    Hospital Clínico Universitario San Carlos
Aug 5, 2022

Lung Cancer ID (Identity) Study

Not yet recruiting
  • Lung Cancer Stage IV
  • Advanced lung cancer patients' group
  • Roma, Italy
  • +1 more
Oct 4, 2023

Relapsed Acute Myeloid Leukemia Trial in Saint Louis (Flotetuzumab, Donor lymphocyte infusion)

Recruiting
  • Relapsed Acute Myeloid Leukemia
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 7, 2022

Cataract Surgery, Glaucoma Surgery Trial (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Ophthalmic Suspension [PRED

Withdrawn
  • Cataract Surgery
  • Glaucoma Surgery
  • Dextenza 0.4Mg Ophthalmic Insert
  • Prednisolone Acetate 1% Ophthalmic Suspension [PRED FORTE]
  • (no location specified)
Nov 16, 2021

Celiac Disease, Celiac Sprue, Gluten Enteropathy Trial in Rochester (Hu-Mik- Beta-1)

Completed
  • Celiac Disease
  • +3 more
  • Hu-Mik- Beta-1
  • Rochester, Minnesota
    Mayo Clinic, Rochester
Jan 16, 2020

CRACK-TARGET 1: ÉTUDE DESCRIPTIVE DE LA SENSIBILISATION

Not yet recruiting
  • Cocaine Use Disorder
  • Observation of behavior and search of biomarkers with 3 blood tests.3 weeks wearing an actimeter
  • 3 blood tests
  • Paris, France
    Hôpital Fernand Widal
Sep 15, 2023

Breast Cancer Trial (GSK3326595)

Completed
  • Breast Cancer
  • London, Ontario, Canada
    St. Joseph's Health Care London
Oct 24, 2022

Leukemia, Myeloid, Acute Trial in United States (VCAR33)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • VCAR33
  • La Jolla, California
  • +9 more
Aug 14, 2023

Ulcerative Colitis Trial in Chestnut Hill (Hydroxocobalamin with Butyrate, Placebo with Butyrate)

Not yet recruiting
  • Ulcerative Colitis
  • Hydroxocobalamin with Butyrate
  • Placebo with Butyrate
  • Chestnut Hill, Massachusetts
    Brigham and Women's Hospital
Mar 4, 2022

Dual Energy Computed Tomography in Thoracic Radiotherapy

Completed
  • Lung Cancer
  • +2 more
  • Thoracic radiotherapy
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal
Nov 11, 2022

Pain Perception, Secondary Hyperalgesia Trial in Basel (Study Intervention: 25 ms half-sine wave stimulation, Control

Recruiting
  • Pain Perception
  • Secondary Hyperalgesia
  • Study Intervention: 25 ms half-sine wave stimulation
  • Control Intervention: 500 µs rectangular shaped stimulation
  • Basel, Switzerland
    Department of Anaesthesiology, University Hospital of Basel (USB
Jun 28, 2022

Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic body radiotherapy (SBRT)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Sep 15, 2023

HTLV-1 Trial run by the NINDS (Hu MiK-Beta-1)

Completed
  • HTLV-1
  • Hu MiK-Beta-1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 26, 2019

Non-Invasive 3D Mapping for Identifying Origin and Preferential

Completed
  • Premature Ventricular Complex
  • Ventricular Arrythmia
  • Non Invasive Electroanatomical Mapping
  • New York, New York
    Lenox Hill Hospital
Apr 18, 2022

Cognitive and Motor Neurological Disorders in Short and Long

Completed
  • Cognitive Disorders
  • +2 more
  • Test battery
  • Tours, France
    University hospital
Sep 5, 2022

Ovarian Cancer Trial in Hungary, United Kingdom, United States (EP0057, Olaparib tablets)

Recruiting
  • Ovarian Cancer
  • Lady Lake, Florida
  • +15 more
Mar 29, 2022

Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)

Not yet recruiting
  • Gastric Cancer
  • Small-cell Lung Cancer
  • Shanghai, Changning District, 交通大学 邮政编码, China
  • +20 more
Nov 1, 2022

Function and Scar in Trigger Finger Release

Recruiting
  • Trigger Finger
  • Trigger Finger Release through Transverse Incision
  • +2 more
  • Hamilton, Ontario, Canada
    St. Joseph's Healthcare
Jul 25, 2022

Gastric Cancer, Peritoneal Metastases, Chemo Effect Trial in London (Doxorubicin and Cisplatin)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • Doxorubicin and Cisplatin
  • London, United Kingdom
    Imperial College London, Hammersmith Hospital Campus
Apr 1, 2022